Altium Capital Management

Altium Capital Management is an investment firm that makes long-term growth capital investments in private and public healthcare companies developing technologies for human health. Founded in 2017 by Jacob Gottlieb, whose background spans healthcare hedge funds, private equity and venture capital, the firm invests across both venture and public markets rather than confining itself to a single asset class.

The firm concentrates on the healthcare sector, with particular attention to therapeutics, biotechnology and pharmaceuticals. It supports early-stage ventures, including companies still in preclinical development, and describes a partnership approach intended to span multiple rounds of financing rather than a single transaction. Assessing such opportunities requires scientific judgement as well as financial analysis; the firm's team combines medical and scientific expertise with professional investment experience, and evaluates prospects through research, due diligence and a network of investors.

Alongside capital, the firm works to help portfolio companies attract additional financing from that investor network - a relevant function in therapeutics and biotechnology, where companies typically raise repeatedly as they progress through development. The stated focus is on technologies directed at human health.